(2S,3S)- 2- ((R)- 4- (4- (2- hydroxyethoxy)phenyl)- 2,5- dioxo- imidazolidin- 1- yl)- 3- phenyl- N- (4- propionylthiazol- 2- yl)butyramide
a mitogen-activated protein kinase kinase 1/2 inhibitor for cancer therapy; structure in first source
Networked: 1
relevant articles (0 outcomes,
0 trials/studies)
Bio-Agent Context: Research Results
Experts
1. | Daouti, Sherif:
1 article
(03/2009)
|
2. | Fotouhi, Nader:
1 article
(03/2009)
|
3. | He, Yang:
1 article
(03/2009)
|
4. | Heimbrook, David:
1 article
(03/2009)
|
5. | Higgins, Brian:
1 article
(03/2009)
|
6. | Huby, Nicholas:
1 article
(03/2009)
|
7. | Kolinsky, Kenneth:
1 article
(03/2009)
|
8. | Kong, Norman:
1 article
(03/2009)
|
9. | Li, Wen-hui:
1 article
(03/2009)
|
10. | Niu, Huifeng:
1 article
(03/2009)
|